Quest Diagnostics News

Quest Diagnostics Discusses Progress in Executing Strategy to Drive Shareholder Value and Presents Outlook at Investor Day 11-05-2014

- Company Expects to Generate 2% to 5% Revenue Growth and Adjusted Diluted EPS Growth of 8% to 10% on Average Over Next Three Years -

Read More

Quest Diagnostics Introduces BRCAvantage Plus™, Providing New Choices in Genetic Breast Cancer Risk Testing 11-04-2014

First major service extension to the company's BRCAvantage™ BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancer

Read More

Quest Diagnostics Unveils New State-of-the-Art Clinical Laboratory in Marlborough, Massachusetts 10-02-2014

Congresswoman Niki Tsongas, Representative Danielle Gregoire and Marlborough Mayor Arthur Vigeant join community event to open 200,000 square-foot "lab of the future" designed to deliver innovative, efficient diagnostic information services to New England

Read More

ExamOne Acquires Assets from OptumInsight 10-27-2014

October 27, 2014

LENEXA, KS, October 27, 2014 / -- ExamOne, a Quest Diagnostics company and leader in helping insurers meet their underwriting needs, is pleased to announce the acquisition of certain proprietary assets from OptumInsight that support the ability to provide rapid responses to data inquiries for use in life and health risk assessments. The acquired assets will streamline and improve the ScriptCheck® service offered through ExamOne.

MedPoint is one of the industry’s leading prescription tools that aggregates and organizes pharmacy claims and eligibility records into health profiles to support life and health insurance risk assessment and medical underwriting. It is integrated with up-to-date prescriber and pharmacy details along with market leading analytics. The development of an efficient channel to obtain this data helps the underwriting and risk assessment process by adding additional value and allowing for a more informed decision to be made by the insurer.

“We have a strong commitment to the insurance industry,” said Troy Hartman, President of ExamOne. “The solutions we provide make the underwriting process more convenient for insurance company home office personnel, agents and applicants. There are 95 million uninsured Americans and we are making great strides in efficiency and improving the experience when applicants apply for life insurance. The enhancements we can bring to the market with this acquisition complement the other solutions we provide to our clients and applicants and will aid in a more simplified underwriting process.”

Along with ExamOne’s expansive suite of insurance services (also known as Policy Express) the acquired technology is designed to accelerate the underwriting process, improve risk assessment, assess the accuracy of health statements and discover undisclosed doctors or medical conditions for underwriters.

ExamOne provides the most robust data information to our clients and is proud to offer the life insurance industry the most extensive access to prescription history through ScriptCheck.

As part of the acquisition, the entire team supporting this OptumInsight product will immediately transition over to ExamOne.

About ExamOne
ExamOne has provided a portfolio of services to the insurance industry since 1972. It has grown significantly through continuous innovation that meets the evolving needs of life, health and disability insurance providers and their customers. Laboratory testing was part of the company’s original services, which over time have expanded to include paramedical examinations, fraud detection, electronic data collection, and gathering attending physician statements and motor vehicle records. ExamOne also has expanded into helping individuals learn about their own health through its Inside Look™ product. (

Read More

Quest Diagnostics Names Mayo Clinic Executive Franklin R. Cockerill, M.D., Vice President and Chief Laboratory Officer 10-01-2014

Former president and CEO of Mayo Medical Laboratories and chair of lab medicine and pathology for Mayo Clinic to oversee Quest's clinical testing operations

Read More

Quest Diagnostics Showcases Care360 EHR

MADISON, New Jersey, March 24, 2011 – Later this month, Quest Diagnostics will demonstrate how physicians can benefit from $39 billion in federal incentives by utilizing Care360™ EHR. The 12-week... Read full article

OVA1 Blood Test Detects Cancer More Accurately

OVA1 Blood Test Detects Ovarian Cancer More Accurately Than Medically Accepted CA 125 Method for Evaluating Women with Ovarian Mass

MADISON, N.J. and AUSTIN, Texas, May 12, 2011 /PRNewswire... Read full article

Quest Diagnostics Reports Strong Performance in Third Quarter 2009

- Total revenues of $1.9 billion, up 3.9%
- Diluted earnings of $1.02 per share, up 26%
- Cash flow from operations of $374 million, up 14%
- 2009 EPS outlook increased to a... Read full article

Contact Us

For more information about our products and services, or to find address, phone or email information, click here.

Take a Virtual Tour

Lab Image Gallery



  • Technicians are overwhelmingly rated as "courteous and professional."*

  • 99% of participants thought appointments were fast and convenient.*

  • 9 out of 10 people would recommend ExamOne to a friend.*

*Based on 2010 survey.